Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 9/20 | 0.62 |
| ▸ | PDGFRA | P16234 | 9/20 | 0.62 |
| ▸ | GAK | O14976 | 1/20 | 0.60 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.50 |
| ▸ | CDK8 | P49336 | 1/20 | 0.50 |
| ▸ | CLK2 | P49760 | 1/20 | 0.50 |
| ▸ | CDK7 | P50613 | 1/20 | 0.50 |
| ▸ | CDK9 | P50750 | 1/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.50 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.50 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | CSF1R | P07333 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26549357 | 1.00 | PDGFRB (0.62) | PDGFRBPDGFRAGAKEGFRMAP4K4 | |
| SCHEMBL26549163 | 0.92 | PDGFRB (0.61) | PDGFRBPDGFRAGAKEGFRESR2 | |
| SCHEMBL26549437 | 0.92 | PDGFRB (0.61) | PDGFRBPDGFRAGAKEGFRESR2 | |
| SCHEMBL26549228 | 0.92 | PDGFRB (0.54) | PDGFRBPDGFRAGAKEGFRMAP4K4 | |
| SCHEMBL26560487 | 0.85 | PDGFRB (0.70) | PDGFRBPDGFRAGAKEGFRMAP4K4 | |
| SCHEMBL26549438 | 0.84 | PDGFRB (0.51) | PDGFRBPDGFRAGAKMAP4K4ESR2 | |
| SCHEMBL26560476 | 0.84 | GAK (0.64) | PDGFRBPDGFRAGAKEGFRMAP4K4 | |
| SCHEMBL26549364 | 0.84 | PDGFRB (0.58) | PDGFRBPDGFRAGAKMAP4K4CLK4 | |
| SCHEMBL26549330 | 0.84 | PDGFRB (0.54) | PDGFRBPDGFRAGAKESR2PIK3CA | |
| SCHEMBL26547982 | 0.82 | MAPK14 (0.53) | MAP4K4DYRK1ACLK4MAPK14MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | PDGFRB 4867/4885PDGFRA 4853/4885GAK 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.